← Leaderboards
Ji Luo
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$394,493,843
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Richard A Gibbs · Baylor College Of Medicine$159,160,442
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary M Horowitz · Medical College Of Wisconsin$153,900,671
- William George Nelson · Johns Hopkins University$111,434,918
Research focus
Cancer CellMalignant NeoplasmsKras2 GeneCellsMutantGeneticMutationGenesCancer Cell LineRna InterferenceOncogenesTumorPathway InteractionsSmall Hairpin RnaMolecularLibrariesProteinsGenetic ScreeningTechnologyIn VitroOncogenicCell LineGenetic AnalysisSignal Transduction
Grant awards (89)
Non-oncogene addiction in cancer cells$1,028,502
ZIA · FY2025 · CA · contact PI
Target discovery and combination therapy in KRAS mutant cancer$514,251
ZIA · FY2025 · CA · contact PI
Organoid models of KRAS mutant cancer$514,251
ZIA · FY2025 · CA · contact PI
Aging and cancer development$257,125
ZIA · FY2025 · CA · contact PI
Methods for mammalian genetic analysis$257,125
ZIA · FY2025 · CA · contact PI
Non-oncogene addiction in cancer cells$610,483
ZIA · FY2024 · CA · contact PI
Organoid models of KRAS mutant cancer$610,483
ZIA · FY2024 · CA · contact PI
Target discovery and combination therapy in KRAS mutant cancer$610,483
ZIA · FY2024 · CA · contact PI
Factors that influence age-dependent Ras mutant cancer development in mice$366,290
ZIA · FY2024 · CA · contact PI
Methods for mammalian genetic analysis$244,193
ZIA · FY2024 · CA · contact PI
Non-oncogene addiction in cancer cells$545,711
ZIA · FY2023 · CA · contact PI
Organoid models of KRAS mutant cancer$545,711
ZIA · FY2023 · CA · contact PI
Target discovery and combination therapy in KRAS mutant cancer$545,711
ZIA · FY2023 · CA · contact PI
Factors that influence age-dependent Ras mutant cancer development in mice$327,426
ZIA · FY2023 · CA · contact PI
Methods for mammalian genetic analysis$218,285
ZIA · FY2023 · CA · contact PI
Non-oncogene addiction in cancer cells$473,481
ZIA · FY2022 · CA · contact PI
Organoid models of KRAS mutant cancer$473,481
ZIA · FY2022 · CA · contact PI
Target discovery and combination therapy in KRAS mutant cancer$473,481
ZIA · FY2022 · CA · contact PI
Methods for mammalian genetic analysis$157,827
ZIA · FY2022 · CA · contact PI
Discovery of combination therapy for KRAS mutant cancer$320,192
ZIA · FY2021 · CA · contact PI
Mechanism of anchorage independent growth driven by the KRAS oncogene$320,192
ZIA · FY2021 · CA · contact PI
Genetic screens for target discovery in cancer$320,192
ZIA · FY2021 · CA · contact PI
Combinatorial genetic analysis using validated siRNA libraries$320,192
ZIA · FY2021 · CA · contact PI
Methods for mammalian genetic analysis$160,096
ZIA · FY2021 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$160,096
ZIA · FY2021 · CA · contact PI
Combinatorial genetic analysis using validated siRNA libraries$283,116
ZIA · FY2020 · CA · contact PI
Mechanism of anchorage independent growth driven by the KRAS oncogene$283,116
ZIA · FY2020 · CA · contact PI
Discovery of combination therapy for KRAS mutant cancer$283,116
ZIA · FY2020 · CA · contact PI
Genetic screens for target discovery in cancer$283,116
ZIA · FY2020 · CA · contact PI
Methods for mammalian genetic analysis$141,558
ZIA · FY2020 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$141,558
ZIA · FY2020 · CA · contact PI
Genetic screens for target discovery in cancer$250,129
ZIA · FY2019 · CA · contact PI
Mechanism of anchorage independent growth driven by the KRAS oncogene$250,129
ZIA · FY2019 · CA · contact PI
Discovery of combination therapy for KRAS mutant cancer$250,129
ZIA · FY2019 · CA · contact PI
Combinatorial genetic analysis using validated siRNA libraries$250,129
ZIA · FY2019 · CA · contact PI
Methods for mammalian genetic analysis$125,064
ZIA · FY2019 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$125,064
ZIA · FY2019 · CA · contact PI
Combinatorial genetic analysis using validated siRNA libraries$201,459
ZIA · FY2018 · CA · contact PI
Mechanism of anchorage independent growth driven by the KRAS oncogene$201,459
ZIA · FY2018 · CA · contact PI
Discovery of combination therapy for KRAS mutant cancer$201,459
ZIA · FY2018 · CA · contact PI
Genetic screens for target discovery in cancer$201,459
ZIA · FY2018 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$100,729
ZIA · FY2018 · CA · contact PI
Methods for mammalian genetic analysis$100,729
ZIA · FY2018 · CA · contact PI
Discovery of combination therapy for KRAS mutant cancer$200,745
ZIA · FY2017 · CA · contact PI
Combinatorial genetic analysis using validated siRNA libraries$200,745
ZIA · FY2017 · CA · contact PI
Genetic screens for target discovery in cancer$200,745
ZIA · FY2017 · CA · contact PI
Mechanism of anchorage independent growth driven by the KRAS oncogene$200,745
ZIA · FY2017 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$100,372
ZIA · FY2017 · CA · contact PI
Methods for mammalian genetic analysis$100,372
ZIA · FY2017 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$211,864
ZIA · FY2016 · CA · contact PI
Discovery of combination therapy for KRAS mutant cancer$211,864
ZIA · FY2016 · CA · contact PI
Genetic screens for target discovery in cancer$211,864
ZIA · FY2016 · CA · contact PI
Combinatorial genetic analysis using validated siRNA libraries$211,864
ZIA · FY2016 · CA · contact PI
Mechanism of anchorage independent growth driven by the KRAS oncogene$105,932
ZIA · FY2016 · CA · contact PI
Methods for mammalian genetic analysis$105,932
ZIA · FY2016 · CA · contact PI
Focused siRNA screening using validated siRNA libraries$286,474
ZIA · FY2015 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$190,982
ZIA · FY2015 · CA · contact PI
The role of RNA splicing factors in Ras transformed cells$190,982
ZIA · FY2015 · CA · contact PI
New shRNA vectors for mammalian genetic analysis$143,237
ZIA · FY2015 · CA · contact PI
Pooled shRNA screens for target discoveries in cancer$143,237
ZIA · FY2015 · CA · contact PI
Role of the protein SUMOylation pathway in Ras-driven oncogenesis$202,104
ZIA · FY2014 · CA · contact PI
Focused siRNA screening using validated siRNA libraries$161,683
ZIA · FY2014 · CA · contact PI
Pooled shRNA screens for target discoveries in cancer$121,263
ZIA · FY2014 · CA · contact PI
The role of RNA splicing factors in Ras transformed cells$121,263
ZIA · FY2014 · CA · contact PI
New shRNA vectors for mammalian genetic analysis$121,263
ZIA · FY2014 · CA · contact PI
Screen for Ras inhibitors$80,842
ZIA · FY2014 · CA · contact PI
Ras oncogene induced protein SUMOylation changes$220,302
ZIA · FY2013 · CA · contact PI
Focused siRNA screening using validated siRNA libraries$176,241
ZIA · FY2013 · CA · contact PI
Alternative splicing in Ras transformed cells$132,181
ZIA · FY2013 · CA · contact PI
New shRNA vectors for mammalian genetic analysis$132,181
ZIA · FY2013 · CA · contact PI
Pooled shRNA screens for target discoveries in cancer$132,181
ZIA · FY2013 · CA · contact PI
Screen for Ras inhibitors$88,121
ZIA · FY2013 · CA · contact PI
Focused siRNA screening using validated siRNA libraries$179,665
ZIA · FY2012 · CA · contact PI
Effect of the Ras oncogene on genomic stability$134,747
ZIA · FY2012 · CA · contact PI
Pooled shRNA screens for target discoveries in cancer$134,747
ZIA · FY2012 · CA · contact PI
Alternative splicing in Ras transformed cells$134,747
ZIA · FY2012 · CA · contact PI
New shRNA vectors for mammalian genetic analysis$134,747
ZIA · FY2012 · CA · contact PI
Ras oncogene induced protein SUMOylation changes$134,747
ZIA · FY2012 · CA · contact PI
Screen for Ras inhibitors$44,916
ZIA · FY2012 · CA · contact PI
Alternative splicing in Ras transformed cells$176,740
ZIA · FY2011 · CA · contact PI
Effect of the Ras oncogene on genomic stability$141,392
ZIA · FY2011 · CA · contact PI
New shRNA vectors for mammalian genetic analysis$141,392
ZIA · FY2011 · CA · contact PI
Ras oncogene induced protein SUMOylation changes$141,392
ZIA · FY2011 · CA · contact PI
Screen for Ras inhibitors$106,044
ZIA · FY2011 · CA · contact PI
Screen for Ras inhibitors$221,286
ZIA · FY2010 · CA · contact PI
New shRNA vectors for mammalian genetic analysis$126,449
ZIA · FY2010 · CA · contact PI
Ras oncogene induced protein SUMOylation changes$126,449
ZIA · FY2010 · CA · contact PI
Effect of the Ras oncogene on genomic stability$94,837
ZIA · FY2010 · CA · contact PI
Sensitivty of MM cells to PLK1 inhibition$63,224
ZIA · FY2010 · CA · contact PI